What to expect this next month now that we sold 1.8 million
What to expect this next month now that we sold 1.8 million shares plus 3/4 warrants for a total of 3.15 million shares not including the Paulson Charge of what 12%. The big questions is will around a half million in funding last us a month with no trials in progress?
Was this just a bandaid to get us to the end of a negotiation? Or will the BOD be smart enough to set up the next round and just release the 700mg Nash results that many investors including my self believe that are spectacular? (The old Recknor drew us in on being excited about the Nash results.) Or will this be a multi news release when it happens? Like here are the Nash results and since they were such awe inspiring we partnered with blank to start a phase 3 trial with all the necessary bio markers that small biotechs only dream of.
When it comes to financing and only having a small sale of 1.8 million when we have so much more to sell for necessary day to day operations and any debt to pay down. This small sale looks like something is about to happen with great news. Or why so little shares being sold? This is what I believe should or could be a news release of some kind very soon. Should we list all the possibilities of news?
1. Nash 700mg results.
2. Nash partner for a phase 3 w/upfront monies
3. mTNBC partner for a phase 3 w/upfront monies.
4. New CEO with all the experience we dream of…
5. Announce that ANVISA restarts our trials.
6. The FDA has been notified that Anvisa approved.
7. New timeline to safety aggregate completion. With approved HIV mono restart of phase 3.
8. Resubmission of BLA as soon as safety aggregate is complete and audit shows all verifiable information has been harvested properly and is acceptable. With a firm new date of submission.
9. That a partnership monies has allowed us to start our FDA approved Long Covid Trial.
If I have left anything of our wish list… feel free to add any additional catalysts that might be coming up.
The big question is which one is the first to bump the stock price? Hmmm? Wouldn’t it be nice if all of them hit in the next 3 months? Oh to dream! As Shelly often says… Let’s go!!!
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...
Continue Reading
Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...
Continue Reading
Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...
Continue Reading
Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...
Continue Reading
A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...
Continue Reading
Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...
Continue Reading
Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...
Continue Reading
RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...
Continue Reading
Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...
Continue Reading
A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...
Continue Reading
Top 5 Most Recently Viewed Articles
Collaboration for Lung Cancer Research Organizations join forces to fund research on the effects of air pollution and climate change in lung cancer. The Lung Cancer Research Foundation (LCRF) and Oncology Advocates United for Climate and Health – International (OUCH-I) are partnering to fund innovative projects aimed at understanding how environmental pollution and...
Continue Reading
Air Products wrapped up a whopping $1.81 billion sale of its liquefied natural gas (LNG) process technology and equipment business to Honeywell. Traders watched as this marked a significant shift, positioning Air Products more firmly in the industrial gases and clean hydrogen markets. The Big Pivot: Air Products' Strategic Shift So why did Air Products sell off the LNG...
Continue Reading
Pony AI Inc. Set to Announce Q3 2025 Earnings Soon Pony AI Inc. (NASDAQ: PONY; HKEX: 2026) is poised to release its financial results for the third quarter of 2025, with expectations mounting among stakeholders and investors. This announcement, set to take place before market opening on November 25, 2025, highlights the company's commitment to transparency and investor...
Continue Reading
Wealth Migration Trends: A Deep Dive into 2025 The changing landscape of global wealth migration in 2025 marks an unprecedented shift, particularly for the UK, which is poised to experience a significant outflow of millionaires. This year, the forecast predicts that a record-breaking number of affluent individuals, totaling approximately 142,000, will consider relocating...
Continue Reading
Overview of Share Repurchase by ICG Enterprise Trust ICG Enterprise Trust plc, often referred to as the Company, has taken a significant step by engaging in a recent share repurchase strategy. The Company announced its intention to buy back 15,000 shares on a specific date, reflecting its commitment to enhancing shareholder value while managing its capital effectively....
Continue Reading